Advances in HER2-positive and HER2-low Breast Cancer

Foundation Frontiers: Advanced Breast Cancer - Updates to HR+/HER2- Treatment LandscapeПодробнее

Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metast...Подробнее

Accelerating Therapeutic Progress in HER2+ and HER2-Low Breast CancerПодробнее

DESTINY-Gastric03: T-DXd in HER2+ and HER2-low gastric cancerПодробнее

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-WynneПодробнее

Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysisПодробнее

Smilow Shares: Breast Cancer Education Series (CME) - Treatment Advances/Clinical TrialsПодробнее

Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline UpdateПодробнее

Recent Advances in HER2 low Breast Cancer ManagementПодробнее

Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Gu...Подробнее

Systemic therapy in operable HER2 positive breast cancerПодробнее

Hot Topics in Advanced Breast Cancer: 2023 Best of Breast ConferenceПодробнее

Management of HER2 positive metastatic breast cancer treatment algorithmПодробнее

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

Spotlight Session 8 HER2 Positive Breast Cancer Novel therapies for HER2+ advanced breast cancerПодробнее

Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology ConferenceПодробнее

NYU Langone's Perlmutter Cancer Center Experts Discuss Advances in Breast Cancer 2022Подробнее

YEAR IN REVIEW Advanced breast cancerПодробнее

Personalized treatment of advanced HER2-negative gastric or gastroesophageal junction cancerПодробнее

Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast ConferenceПодробнее